Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.

PubWeight™: 8.76‹?› | Rank: Top 0.1%

🔗 View Article (PMC 2964270)

Published in Hepatology on June 01, 1993


T E Starzl1, A J Demetris, M Trucco, N Murase, C Ricordi, S Ildstad, H Ramos, S Todo, A Tzakis, J J Fung

Author Affiliations

1: Department of Surgery, University of Pittsburgh Health Science Center, Pennsylvania 15213.

Articles citing this

(truncated to the top 100)

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09

Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest (2008) 2.73

Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20

Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20

Transplantation tolerance from a historical perspective. Nat Rev Immunol (2001) 2.04

Human allograft acceptance is associated with immune regulation. J Clin Invest (2000) 1.94

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93

Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med (1995) 1.88

Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation (1996) 1.86

Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (1995) 1.83

Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81

The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81

Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth (1998) 1.67

Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liver. Transplantation (1996) 1.65

Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs. Transplantation (2012) 1.63

Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61

Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation (1995) 1.59

Weaning of immunosuppression in long-term liver transplant recipients. Transplantation (1995) 1.59

Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57

The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56

Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53

Split tolerance induced by orthotopic liver transplantation in mice. Transplantation (1994) 1.52

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52

Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation (1995) 1.51

Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44

Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J Exp Med (1995) 1.42

Abdominal multivisceral transplantation. Transplantation (1995) 1.37

Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33

The current status of small bowel transplantation in the UK and internationally. Gut (2005) 1.31

Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29

Current status of intestinal transplantation in children. J Pediatr Surg (1998) 1.28

Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc (1995) 1.24

Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism. Transplantation (1995) 1.19

Dendritic cells and immune regulation in the liver. Gut (2003) 1.19

Immune status of recipients following bone marrow-augmented solid organ transplantation. Transplantation (1995) 1.18

Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation (1994) 1.16

Donor-derived chimerism in recipients of organ transplants. Hepatology (1993) 1.15

Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest (2006) 1.13

Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. J Hepatol (2008) 1.10

Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant (1997) 1.09

Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol (1995) 1.08

Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc (1993) 1.08

Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Liver Transpl (2000) 1.07

Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07

Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc (1997) 1.07

Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci (1994) 1.06

Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts. Transplantation (1999) 1.04

The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest (1997) 1.02

Combined bone marrow and whole organ transplantation from the same donor. Transplant Proc (1994) 1.02

Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation (1996) 1.02

Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. Transplant Proc (1995) 0.99

Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients. Ann Thorac Surg (1995) 0.98

Combined simultaneous kidney/bone marrow transplantation. Transplantation (1995) 0.98

Themes of liver transplantation. Hepatology (2010) 0.98

Prospects of clinical xenotransplantation. Transplant Proc (1994) 0.98

Composite tissue allotransplantation immunology. Arch Plast Surg (2013) 0.97

Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data. Ann Rheum Dis (2003) 0.97

Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97

Interactions of allogeneic human mononuclear cells in the two-way mixed leucocyte culture (MLC): influence of cell numbers, subpopulations and cyclosporin. Clin Exp Immunol (1999) 0.97

The politics of grafting cadaver kidneys. Lancet (1996) 0.95

Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation (2004) 0.94

The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93

Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. Transplant Proc (1997) 0.92

Human dendritic cells and transplant outcome. Transplantation (2008) 0.92

Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation (1999) 0.92

Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc (1998) 0.91

Explanation for loss of the HLA matching effect. Transplant Proc (1995) 0.91

Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays. Hum Immunol (2010) 0.91

Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation (1994) 0.91

History of clinical transplantation. World J Surg (2000) 0.91

Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies. Am J Kidney Dis (1994) 0.90

Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc (1996) 0.90

HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation (1997) 0.89

Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation. World J Gastroenterol (2012) 0.89

Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol (2003) 0.89

Liver transplants contribute to their own success. Nat Med (1996) 0.89

Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med (2008) 0.88

Small intestinal transplantation for irreversible intestinal failure in children. Dig Dis Sci (1997) 0.87

Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting. Cytotherapy (2011) 0.87

Identification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients. Transplantation (1995) 0.87

Bone marrow augmentation in renal transplant recipients. Transplant Proc (1998) 0.86

Marking a path to transplant tolerance. J Clin Invest (2008) 0.85

The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience. Clin Transpl (1995) 0.85

New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol Rev (1993) 0.84

Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation. Transplant Proc (1997) 0.84

Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus. Transplantation (1997) 0.84

A new protocol for the propagation of dendritic cells from rat bone marrow using recombinant GM-CSF, and their quantification using the mAb OX-62. J Immunol Methods (1995) 0.84

Bone marrow-derived chimerism in non-irradiated, cyclosporin-treated rats receiving microvascularized limb transplants: evidence for donor-derived dendritic cells in recipient lymphoid tissues. Immunology (1995) 0.84

Early tolerance in pediatric liver allograft recipients. J Pediatr Surg (1994) 0.84

Articles cited by this

(truncated to the top 100)

The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09

Actively acquired tolerance of foreign cells. Nature (1953) 19.82

Evolution of liver transplantation. Hepatology (1982) 19.54

The behaviour and fate of skin autografts and skin homografts in rabbits: A report to the War Wounds Committee of the Medical Research Council. J Anat (1944) 16.73

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 13.88

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24


Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med (1974) 7.58


The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89


Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo. J Exp Med (1974) 6.60

Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell (1990) 6.33

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med (1963) 5.14

Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med (1982) 5.09

Transplantation of small bowel in the rat: technical and immunological considerations. Surgery (1971) 5.05

Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med (1981) 5.00

Effect of cortisone on survival of skin homografts in rabbits. Br Med J (1951) 4.98

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Successful small-bowel/liver transplantation. Lancet (1990) 4.85

Kidney transplantation in modified recipients. Ann Surg (1962) 4.66

Liver transplantation (1). N Engl J Med (1989) 4.53

Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet (1968) 4.41

Homotransplantation of multiple visceral organs. Am J Surg (1962) 4.28

Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature (1984) 4.26

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59


Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med (1977) 3.48

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Reversal of transplantation immunity by liver grafting. Nature (1981) 3.07

Renal homotransplantation in man after radiation of the recipient. Experience with six patients since 1959. Am J Med (1962) 3.04

Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91

The homograft reaction. Annu Rev Microbiol (1957) 2.89

Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80

Prolongation of survival of skin homotransplants in the rabbit by irradiation of the host. Br J Exp Pathol (1950) 2.79

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation (1990) 2.59

Soluble HLA antigens in the circulation of liver graft recipients. Transplantation (1989) 2.48

Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med (1984) 2.44

Anomalous ABO phenotype in a child after an ABO-incompatible liver transplantation. N Engl J Med (1992) 2.36

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation (1991) 2.32

Liver transplantation for type IV glycogen storage disease. N Engl J Med (1991) 2.31

Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc (1991) 2.28


Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med (1984) 2.25

Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation (1993) 2.17

Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst (1955) 2.16

Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14

FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation (1990) 2.13

Study on transplantation immunity after total body irradiation: clinical and experimental investigation. Surgery (1960) 2.07

Immunization with skin isografts taken from tolerant mice. Science (1967) 2.05

Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation. Pediatrics (1986) 2.04

Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest (1966) 2.01


[Liver transplantation in the pig: surgical approach]. C R Acad Sci Hebd Seances Acad Sci D (1965) 1.98

Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation (1993) 1.94

Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc (1991) 1.89

Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med (1986) 1.89

Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med (1979) 1.88

Effect of organ culture on the survival of thyroid allografts in mice. Transplantation (1976) 1.83


Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science (1976) 1.80

Homologous human kidney transplantation. Experience with six patients. Postgrad Med J (1962) 1.80

Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci U S A (1981) 1.77

PCR amplification of chromosome-specific alpha satellite DNA: definition of centromeric STS markers and polymorphic analysis. Genomics (1991) 1.74

Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis. Proc Natl Acad Sci U S A (1966) 1.72

Successful small bowel transplantation in an infant. Transplantation (1992) 1.69

Observations of orthotopic liver transplantation in the pig. Br Med J (1967) 1.69

Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68

Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol (1985) 1.65

The application of bone marrow transplantation to the treatment of genetic diseases. Science (1986) 1.62

Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation (1988) 1.61

Techniques for orthotopic liver transplantation in the rat and some studies of the immunologic responses to fully allogeneic liver grafts. Transplant Proc (1979) 1.61

Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression. Lancet (1992) 1.61

Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med (1988) 1.59

Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58

PCR detection of distal Yp sequences in an XX true hermaphrodite. Am J Med Genet (1991) 1.54

Drug development and testing in relation to cell migration and chimerism. Transplant Proc (1993) 1.52

The influence for cortisone on the survival of homografts of skin in the rabbit. Surgery (1951) 1.51

Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A. Am J Med Genet (1977) 1.51

Severe cardiopathy in branching enzyme deficiency. J Pediatr (1987) 1.41

Nervous system involvement in type IV glycogenosis. Arch Pathol Lab Med (1979) 1.40

Medawar's legacy to cellular immunology and clinical transplantation: a commentary on Billingham, Brent and Medawar (1956) 'Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance'. Philos Trans R Soc Lond B Biol Sci (2015) 1.40

Cell migration and chimerism--a unifying concept in transplantation--with particular reference to HLA matching and tolerance induction. Transplant Proc (1993) 1.40

Class I transplantation antigens in solution in body fluids and in the urine. Individuality signals to the environment. J Exp Med (1988) 1.39

Post transplantation donor-specific bone marrow transfusion in polyclonal antilymphocyte serum-treated recipients: the optimal cellular antigen for induction of unresponsiveness to organ allografts. Transplant Proc (1988) 1.38

Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc (1988) 1.38

Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens. J Exp Med (1987) 1.34

The transplantation of normal tissues: with special reference to auto- and homotransplants of thyroid and spleen in the anterior chamber of the eye, and subcutaneously, in guinea-pig. Philos Trans R Soc Lond B Biol Sci (1950) 1.33

Donor dendritic cell repopulation in recipients after rat-to-mouse bone-marrow transplantation. Lancet (1992) 1.32

Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med (1989) 1.29

Graft-versus-host disease in solid organ transplantation. Transpl Int (1991) 1.27

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Bone marrow as a potential source of hepatic oval cells. Science (1999) 8.52

Kidney transplantation under FK 506. JAMA (1990) 7.45

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Liver transplantation (1). N Engl J Med (1989) 4.53

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet (1997) 3.70

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54


Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11